Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04183218 · ClinicalTrials.gov registry record
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
A clinical trial of Clinical Stage III Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Adenocarcinoma AJCC v8, sponsored by Mayo Clinic.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT04183218 is a study of Clinical Stage III Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Adenocarcinoma AJCC v8 that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 105-participant average among 12 other Clinical Stage III Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04183218, a study of Clinical Stage III Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Adenocarcinoma AJCC v8, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies cardiac changes after radiation or chemo-radiation for the treatment of lung or esophageal cancer that has not spread to other places in the body (non-metastatic) or has not come back (non-recurrent). Continuous cardiac monitoring with an implanted device may help to identify cardiac changes that would remain unnoticed, and facilitate the treatment of these early cardiac changes as part of standard care.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- RADIATION Radiation Therapy
- OTHER Chemoradiotherapy
- DEVICE Cardiac Event Monitor
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2024-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04183218
The ClinicalTrials.gov registry entry for NCT04183218 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 105-participant average among 12 other Clinical Stage III Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (77% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Clinical Stage III Esophageal Adenocarcinoma AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT04183218 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04183218 about?
NCT04183218 is a clinical study titled "Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes". This trial studies cardiac changes after radiation or chemo-radiation for the treatment of lung or esophageal cancer that has not spread to other places in the body (non-metastatic) or has not come back (non-recurrent). Continuous cardiac monitoring with an implanted device may help to identify card...
What is the current status of trial NCT04183218?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2019-09-23. Estimated completion is 2024-05-02.
What conditions does trial NCT04183218 study?
This clinical trial studies the following conditions: Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Adenocarcinoma AJCC v8.
What interventions are being tested in trial NCT04183218?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Radiation Therapy (RADIATION), Chemoradiotherapy (OTHER), Cardiac Event Monitor (DEVICE).
Who is sponsoring clinical trial NCT04183218?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04183218 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RECRUITING · Phase 2
-
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RECRUITING · Phase 3
-
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
RECRUITING · Phase 3
-
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Clinical Stage III Esophageal Adenocarcinoma AJCC v8
All registered trials for this condition
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.